Leo Pharma Investigational Site

Missoula, Montana 59808

We've found

2 trials

at this facility

Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Missoula, MT

Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Missoula, MT

Use our guide to learn which trials are right for you!